PIPELINE

AtN platform technology has the potential to achieve neuroregeneration in a variety of neurodegenerative conditions. NeuExcell has a robust pipeline with three leading programs: Stroke, HD and ALS.

Indication
Discovery
Candidate Optimization
IND Enabling
FIH Study
Ischemic Cortical Stroke
NXL-001
IND Q4'23
Huntington's Disease
NXL-002
IND Q2'24
Amyotrophic Lateral Sclerosis
NXL-003
IIT Q2'23
Retinal Diseases
Glioma
Alzheimer's Disease
Temporal Lobe Epilepsy
Traumatic Brain Injury
Parkinson's Disease